Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01206036
What this trial is testing

CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)

Who this might be right for
Prostatic Neoplasms
Central European Society for Anticancer Drug Research 19
Large-scale testing (Phase 3)Study completedNCT00638690
What this trial is testing

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Prostatic Neoplasms
Cougar Biotechnology, Inc. 1,195
Testing effectiveness (Phase 2)Ended earlyNCT05633160
What this trial is testing

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

Who this might be right for
Prostatic NeoplasmsCastration-Resistant
Clarity Pharmaceuticals Ltd 4
Testing effectiveness (Phase 2)Study completedNCT02036060
What this trial is testing

Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.

Who this might be right for
Metastatic Prostate Cancer
Spanish Oncology Genito-Urinary Group 119
Testing effectiveness (Phase 2)Ended earlyNCT04102124
What this trial is testing

SHR3680 in Combination With SHR3162 in the Treatment of mCRPC

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 20
Early research (Phase 1)UnknownNCT03780075
What this trial is testing

Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital 50
Not applicableUnknownNCT04188275
What this trial is testing

CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION

Who this might be right for
D011471D064129D035683+2 more
Azienda Ospedaliero-Universitaria Careggi 46
Early research (Phase 1)Ended earlyNCT02349139
What this trial is testing

Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Cancer of the ProstateNeoplasms, ProstateProstate Cancer+3 more
Asana BioSciences 27
Testing effectiveness (Phase 2)UnknownNCT04824937
What this trial is testing

Telaglenastat + Talazoparib In Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Massachusetts General Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06764485
What this trial is testing

Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Celgene 960
Testing effectiveness (Phase 2)UnknownNCT06251492
What this trial is testing

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Fudan University 30
Early research (Phase 1)Study completedNCT02162836
What this trial is testing

A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Janssen Pharmaceutical K.K. 6
Testing effectiveness (Phase 2)Ended earlyNCT03261336
What this trial is testing

Oral Calcitriol With Ketoconazole in CRPC

Who this might be right for
Castration-resistant Prostate Cancer
Donald Trump, MD 1
Testing effectiveness (Phase 2)Looking for participantsNCT06155084
What this trial is testing

Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Hinova Pharmaceuticals Inc. 84
Large-scale testing (Phase 3)Study completedNCT02288247
What this trial is testing

Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Europe Ltd. 688
Testing effectiveness (Phase 2)Study completedNCT02278055
What this trial is testing

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerPain
Memorial Sloan Kettering Cancer Center 29
Large-scale testing (Phase 3)Study completedNCT02987543
What this trial is testing

Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 387
Testing effectiveness (Phase 2)UnknownNCT04926155
What this trial is testing

The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 234
Large-scale testing (Phase 3)Study completedNCT00744497
What this trial is testing

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bristol-Myers Squibb 1,930
Early research (Phase 1)Not Yet RecruitingNCT07683013
What this trial is testing

Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)
Hyundai Bioscience Co., Ltd. 18
Next Page